Lenacapavir Shows Viral Suppression in Drug-Resistant HIV Lenacapavir Shows Viral Suppression in Drug-Resistant HIV

The novel drug, given every 6 months in combination with optimized ART, shows viral suppression in new 26-week data.Medscape Medical News

Source: Medscape Medical News Headlines - July 20, 2021 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news